These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35532871)

  • 1. Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo.
    Brautaset Englund KV; Østby CM; Broch K; Ueland T; Aukrust P; Gude E; Andreassen AK; Gullestad L
    Clin Transplant; 2022 Jul; 36(7):e14695. PubMed ID: 35532871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial.
    Brautaset Englund KV; Østby CM; Rolid K; Gude E; Andreassen AK; Gullestad L; Broch K
    J Heart Lung Transplant; 2021 May; 40(5):359-367. PubMed ID: 33612360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemojuvelin and iron metabolism in kidney and heart allograft recipients.
    Przybylowski P; Koc-Zorawska E; Glowinska I; Levin-Iaina N; Macdougall IC; Malyszko JS; Mysliwiec M; Malyszko J
    Transplant Proc; 2013; 45(1):391-3. PubMed ID: 23375327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude.
    Goodrich JA; Frisco DJ; Kim S; VanBaak K; Holliday M; Rueda M; Poddar S; Byrnes WC
    Int J Sports Physiol Perform; 2022 Dec; 17(12):1716-1724. PubMed ID: 36343619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world experience of intravenous iron sucrose supplementation and dynamics of soluble transferrin receptor and hepcidin in a Spanish cohort of absolute iron deficient patients.
    Tarancon-Diez L; Iriarte-Gahete M; Sanchez-Mingo P; Perez-Cabeza G; Romero-Candau F; Pacheco YM; Leal M; Muñoz-Fernández MÁ
    Biomed Pharmacother; 2023 Nov; 167():115510. PubMed ID: 37757490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency.
    Tarancon-Diez L; Genebat M; Roman-Enry M; Vázquez-Alejo E; Espinar-Buitrago MS; Leal M; Muñoz-Fernandez MÁ
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Mendoza E; Duque X; Moran S; Martínez-Andrade G; Reyes-Maldonado E; Flores-Huerta S; Martinez H
    Ann Hematol; 2021 Apr; 100(4):879-890. PubMed ID: 33515046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in iron homeostasis in human experimental and clinical malaria.
    Woolley SD; Grigg MJ; Marquart L; Gower JSE; Piera K; Nair AS; Amante FM; Rajahram GS; William T; Frazer DM; Chalon S; McCarthy JS; Anstey NM; Barber BE
    EBioMedicine; 2024 Jul; 105():105189. PubMed ID: 38851058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
    Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
    Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
    Docherty KF; Welsh P; Verma S; De Boer RA; O'Meara E; Bengtsson O; Køber L; Kosiborod MN; Hammarstedt A; Langkilde AM; Lindholm D; Little DJ; Sjöstrand M; Martinez FA; Ponikowski P; Sabatine MS; Morrow DA; Schou M; Solomon SD; Sattar N; Jhund PS; McMurray JJV;
    Circulation; 2022 Sep; 146(13):980-994. PubMed ID: 35971840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure.
    Packer M
    JACC Heart Fail; 2023 Jan; 11(1):106-114. PubMed ID: 36396554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure.
    Lanser L; Poelzl G; Messner M; Ungericht M; Zaruba MM; Hirsch J; Hechenberger S; Obersteiner S; Koller B; Ulmer H; Weiss G
    J Am Heart Assoc; 2024 May; 13(9):e032540. PubMed ID: 38639356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
    Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
    J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.
    Minchella PA; Armitage AE; Darboe B; Jallow MW; Drakesmith H; Jaye A; Prentice AM; McDermid JM
    J Nutr; 2015 Jun; 145(6):1194-201. PubMed ID: 25904736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
    Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
    Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron status in patients with chronic heart failure.
    Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients.
    Garrido-Rodríguez V; Álvarez-Ríos AI; Olivas-Martínez I; Pozo-Balado MDM; Bulnes-Ramos Á; Leal M; Pacheco YM
    Front Immunol; 2022; 13():977316. PubMed ID: 36505484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Serum Iron Metabolism-Related Markers in Patients with Nasopharyngeal Carcinoma.
    Mei J; Xiao X; Liang N; Dong L; Wei S; Mo L; Zhao W; Cai Y
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(4):223-230. PubMed ID: 37311432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.